DexCom
San Diego, US · 1 known investors
Biotechin /dexcom
Founders & leadership
RK
Richard K. DoubledayExecutive Officer
ET
Eric T. TopolDirector
BE
Barbara E. KahnDirector
SR
Steven R. PacelliExecutive Officer
JT
Jonathan T. LordDirector
JD
Jeffrey D. MoyExecutive Officer
NH
Nicholas H. AugustinosDirector
TH
Terrance H. GreggExecutive Officer, Director
JR
Jorge R. ValdesExecutive Officer
JD
John D. ListerExecutive Officer
JR
Jess R. RoperExecutive Officer
AK
Andrew K. BaloExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$7.2MraisedMay 2016 · 2 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.